Search research articles
Contact Us
Filters
Showing results (211-220 of 247) with videos related to
Page
of 25
Sort By:
Infection and Drug Resistance
|
September 27, 2021
High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant <i>Acinetobacter baumannii</i>: An Observational Cohort Study
Hui Han, Weidong Qin, Yue Zheng, et al.
BMC Geriatrics
|
March 30, 2023
Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution
Huiyao Huang, Yu Tang, Dawei Wu, et al.
Biochemical and Biophysical Research Communications
|
March 26, 2021
Tubular epithelial cells derived-exosomes containing CD26 protects mice against renal ischemia/reperfusion injury by maintaining proliferation and dissipating inflammation
Juan Du, Qiang Sun, Zhihao Wang, et al.
Asia-Pacific Journal of Oncology Nursing
|
October 31, 2022
Consensus on informed consent for participants in cancer clinical studies (2021 edition)
Dawei Wu, Meimei Chen, Jing Liang, et al.
Frontiers in Immunology
|
September 30, 2022
Association between germ-line HLA and immune-related adverse events
Ning Jiang, Yue Yu, Min Zhang, et al.
British Journal of Cancer
|
May 15, 2018
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
Hongnan Mo, Jing Huang, Jiachen Xu, et al.
ACS Nano
|
January 18, 2025
Efficient Nitrate to Ammonia Conversion on Bifunctional IrCu<sub>4</sub> Alloy Nanoparticles
Ning He, Zhi Yuan, Chao Wu, et al.
The Lancet. Oncology
|
November 3, 2022
Accelerating the integration of China into the global development of innovative anticancer drugs
Huiyao Huang, Dawei Wu, Huilei Miao, et al.
Science Advances
|
June 19, 2026
Synchronous wearable ultrasound for early detection of coronary and carotid artery comorbidity
Shengrong Lin, Hao Xu, Ya Li, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2021
Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial
Bo Zhang, Jing Huang, Jialin Tang, et al.
Page
of 25
Search research articles
Search
Showing results (211-220 of 247) with videos related to
Sort By:
Page
of 25
Infection and Drug Resistance
|
September 27, 2021
High-Dose versus Standard-Dose Tigecycline Treatment of Secondary Bloodstream Infections Caused by Extensively Drug-Resistant <i>Acinetobacter baumannii</i>: An Observational Cohort Study
Hui Han, Weidong Qin, Yue Zheng, et al.
BMC Geriatrics
|
March 30, 2023
Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution
Huiyao Huang, Yu Tang, Dawei Wu, et al.
Biochemical and Biophysical Research Communications
|
March 26, 2021
Tubular epithelial cells derived-exosomes containing CD26 protects mice against renal ischemia/reperfusion injury by maintaining proliferation and dissipating inflammation
Juan Du, Qiang Sun, Zhihao Wang, et al.
Asia-Pacific Journal of Oncology Nursing
|
October 31, 2022
Consensus on informed consent for participants in cancer clinical studies (2021 edition)
Dawei Wu, Meimei Chen, Jing Liang, et al.
Frontiers in Immunology
|
September 30, 2022
Association between germ-line HLA and immune-related adverse events
Ning Jiang, Yue Yu, Min Zhang, et al.
British Journal of Cancer
|
May 15, 2018
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
Hongnan Mo, Jing Huang, Jiachen Xu, et al.
ACS Nano
|
January 18, 2025
Efficient Nitrate to Ammonia Conversion on Bifunctional IrCu<sub>4</sub> Alloy Nanoparticles
Ning He, Zhi Yuan, Chao Wu, et al.
The Lancet. Oncology
|
November 3, 2022
Accelerating the integration of China into the global development of innovative anticancer drugs
Huiyao Huang, Dawei Wu, Huilei Miao, et al.
Science Advances
|
June 19, 2026
Synchronous wearable ultrasound for early detection of coronary and carotid artery comorbidity
Shengrong Lin, Hao Xu, Ya Li, et al.
Journal for Immunotherapy of Cancer
|
April 10, 2021
Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial
Bo Zhang, Jing Huang, Jialin Tang, et al.
Page
of 25